Single-Cell Passaging of Human iPSC: A Step-by-Step Dissociation Protocol

This single-cell passaging protocol for human iPSC covers the full cycle from a confluent, undifferentiated culture to a re-plated single-cell suspension: reagent choice, incubation endpoints, ROCK-inhibitor dosing and timing, seeding density, and the genomic-stability monitoring that single-cell work makes non-optional. It is written reagent-neutral — the same method runs with EDTA, Accutase®, a TrypLE™-type recombinant enzyme, or an animal-origin-free recombinant trypsin-like enzyme — with an explicit note at the end on which of those choices is supported by published data and which is not.

When Single-Cell Passaging Is Actually Required

Four situations genuinely need a single-cell suspension:

• Defined seeding density. Directed differentiation protocols are density-sensitive, and you cannot count clumps.
• Clonal isolation. Subcloning after gene editing needs one cell per well.
• Flow cytometry or FACS. Doublets and clumps ruin gating and clog the nozzle.
• Single-cell genomics. Droplet and plate-based platforms specify a single-cell input with a defined multiplet tolerance.

For everything else — expanding a line, banking, keeping a culture ticking over between experiments — clump passaging is the safer default. In a study covering more than 100 continuous passages of human ES and iPS cells, enzymatic passaging and feeder-free culture were each associated with genetic instability, faster proliferation, and recurrent deletions in the genomic region containing TP53; the effect of enzymatic passaging was the stronger of the two (Garitaonandia et al., PLoS One 2015).

Why Dissociated hPSC Die, and What Actually Prevents It

Human pluripotent stem cells survive poorly as single cells. The mechanism is well characterised and it is not classical anoikis. Loss of E-cadherin-dependent cell–cell contact triggers a Rho-high / Rac-low state that hyperactivates ROCK and actomyosin contraction, and that contraction kills the cell (Ohgushi et al., Cell Stem Cell 2010). Independently, inhibiting myosin heavy-chain ATPase, or knocking down myosin heavy or light chain, each raised survival and cloning efficiency of individualised human ES cells — confirming actin–myosin contractility as the effector (Chen et al., Cell Stem Cell 2010).

This is why the ROCK inhibitor Y-27632 is in the protocol and not optional. In the original report, Y-27632 markedly reduced dissociation-induced apoptosis and raised cloning efficiency from roughly 1% to roughly 27% (Watanabe et al., Nat Biotechnol 2007). Two practical consequences follow:

• The enzyme is not the main determinant of survival. A gentler enzyme with no ROCK inhibitor will still give poor recovery.
• Anything that prolongs the single-cell state before attachment — a long centrifugation, a slow count, a delayed plating — costs you cells. Keep the interval short.

Materials and Reagents

• Undifferentiated human iPSC culture at 70–85% confluence, with no visible differentiated regions
• Chemically defined maintenance medium, pre-warmed (E8-type medium and vitronectin-coated surfaces are a defined, albumin-free reference system; Chen et al., Nat Methods 2011)
• Coated culture vessels — vitronectin, laminin-521 or an equivalent defined matrix, prepared per the matrix datasheet
• Dissociation reagent (see the comparison table below)
• Sterile DPBS without Ca²⁺ and Mg²⁺
• ROCK inhibitor Y-27632, typically 10 µM final, or an equivalent validated ROCK inhibitor
• 0.4% trypan blue and a haemocytometer or automated counter
• Optional: 37 µm or 40 µm cell strainer for platform work that specifies a multiplet ceiling
• Class II cabinet, 37 °C / 5% CO₂ incubator, inverted microscope, benchtop centrifuge

Single-Cell Passaging Protocol: Step by Step

Volumes below assume one well of a 6-well plate (9.6 cm²). Scale by growth area for other vessels.

1. Inspect and clean the culture. Examine under the microscope. Colonies should be compact with defined edges. Mechanically remove any differentiated regions before you start — single-cell passaging will otherwise carry that population forward and enrich it.
2. Coat the destination vessel. Prepare the coated plate ahead of the dissociation so that plating follows counting immediately. Add pre-warmed medium containing 10 µM Y-27632 to the destination wells and place them in the incubator to equilibrate.
3. Aspirate the spent medium and wash. Add 1–2 mL DPBS without Ca²⁺/Mg²⁺, rock gently, aspirate. The wash removes residual medium and begins loosening divalent-cation-dependent adhesion.
4. Add the dissociation reagent. Use just enough to cover the monolayer — roughly 1 mL per 25 cm², so about 0.4 mL for one well of a 6-well plate. Rock to cover evenly; patchy coverage gives patchy dissociation and a clumpy suspension.
5. Incubate and watch. Incubate at 37 °C and check from 2 minutes onward. The endpoint is the moment colony borders begin to loosen and individual cells round up, typically 3–7 minutes depending on the reagent and the line. Do not incubate by the clock. Over-digestion is the single largest avoidable cause of poor recovery here, and the damage is not visible in a trypan blue count.
6. Quench and collect. Add at least twice the enzyme volume of medium containing 10 µM Y-27632, or the inhibitor appropriate to your reagent. Recombinant trypsin-like enzymes designed for dilution quenching need no separate inhibitor — check your reagent's instructions rather than assuming. Rinse the growth surface with the medium to collect loosely attached cells.
7. Disperse to single cells. Pipette gently up and down 3–5 times with a P1000 against the well base. Stop as soon as the suspension looks even. Aggressive trituration shears membranes and does more damage than a slightly longer incubation would have.
8. Centrifuge. 200–300 × g for 3–5 minutes. Aspirate the supernatant and resuspend in medium containing 10 µM Y-27632. Keep this step short — cells are in the vulnerable dissociated state throughout.
9. Count. Mix an aliquot 1:1 with 0.4% trypan blue and count. Expect >85–90% viability from a well-executed dissociation. A lower figure points at over-digestion, harsh pipetting, or a culture that was not healthy to begin with.
10. Optional — strain. Pass through a 37–40 µm strainer when a downstream platform specifies a multiplet ceiling. Skip it for routine expansion; it costs yield.
11. Seed. Plate at your validated density — a common starting range for expansion is 1–2 × 10⁴ cells/cm², but this is line- and medium-dependent and must be titrated in your own hands. Distribute with a gentle figure-of-eight, return to the incubator, and do not disturb the plate for at least 24 hours.
12. Remove the ROCK inhibitor at the first medium change. Standard practice is a full medium change to Y-27632-free medium at 24 hours after plating. Record the passage number and date.

Choosing a Dissociation Reagent

Four reagent classes are in routine use for hPSC. The honest position on each:

Whichever you choose, fix the exposure time and hold it constant across an experiment. Protease exposure removes surface proteins, and marker loss can occur well before viability drops — two arms that used different incubation times are not comparable, whatever the viability counts say. A fuller side-by-side is in TrypLE vs trypsin vs Accutase.

ROCK Inhibitor: Dose, Timing and Its Limits

Y-27632 at 10 µM in the plating medium, removed at the first medium change 24 hours later, is the conventional regimen and the one this protocol assumes. Three practical points:

• Add it before, not after. The inhibitor must be present in the medium the cells land in. Adding it once cells are already plated and dying does not rescue them.
• Do not leave it on. ROCK inhibition changes cytoskeletal state and morphology. Continuous exposure past the recovery window is a confound in any downstream morphology, migration or differentiation readout.
• It does not license over-digestion. Y-27632 suppresses dissociation-induced apoptosis; it does not repair a cell that has had its surface proteins stripped by ten minutes of unnecessary protease exposure.

Genomic Stability: What Single-Cell Passaging Costs You

This is the part of the protocol most often skipped, and the one most likely to invalidate a year of work.

The International Stem Cell Initiative analysed 125 human ES lines and 11 iPS lines from 38 laboratories. Most lines stayed karyotypically normal, but there was a progressive tendency to acquire changes on prolonged culture, commonly affecting chromosomes 1, 12, 17 and 20; a minimal amplicon at 20q11.21 containing ID1, BCL2L1 and HM13 occurred in more than 20% of lines, with BCL2L1 the strong candidate for driving culture adaptation (International Stem Cell Initiative, Nat Biotechnol 2011). The mechanism is straightforward selection: a variant that survives dissociation better takes over the culture. Single-cell passaging applies exactly that selection pressure, repeatedly.

Practical minimum:

• Karyotype or an equivalent copy-number assay at least every 10 passages, and always before banking or before a definitive experiment.
• Include the recurrent hotspots — 20q11.21, chromosome 12, chromosome 17 — in whatever targeted assay you use if you are not doing full karyotyping.
• Keep a low-passage frozen stock and return to it rather than carrying a line indefinitely.
• Record the passage number every single time. A line without a passage history cannot be interpreted.

Troubleshooting

Where an Animal-Origin-Free Enzyme Fits — and What the Data Does Not Cover

Laboratories moving toward xeno-free or clinical-grade workflows replace porcine trypsin with a recombinant, animal-origin-free enzyme to remove TSE/BSE and adventitious-agent risk and to cut lot-to-lot variability. CellTrypase (c-LEcta GmbH, a Kerry company) is one such option: a recombinant trypsin-like serine protease from a Fusarium oxysporum gene expressed in a Bacillus sp. host, ~22 kDa, cleaving after lysine and arginine, ≥95% purity by HPLC, formulated in PBS with 1.1 mM EDTA and sterile filtered, animal-origin-free, endotoxin ≤1 EU/mL at 1×, mycoplasma negative, sterility per Ph. Eur. 2.6.1 / USP <71>. It is quenched by dilution in buffer or medium, so no trypsin inhibitor is needed, and it is stable for at least 15 months at 2–8 °C. Matched R&D grade (ISO 9001:2015) and GMP grade (EXCiPACT® GMP/GDP) come from the same manufacturer.

For the routine adherent-line version of this method see the CellTrypase cell dissociation protocol, the reagent-neutral trypsinization protocol, and the CellTrypase specifications guide.

Frequently Asked Questions

How long should I incubate iPSC in the dissociation reagent?

Until colony borders loosen and cells round up — typically 3–7 minutes at 37 °C, but the number depends on the reagent, the line, the confluence and the matrix. Watch under the microscope and stop at the endpoint. An extra three minutes “to be safe” is the most common way to ruin an otherwise good passage.

Do I have to use a ROCK inhibitor?

For single-cell passaging of human pluripotent stem cells, effectively yes. Dissociated hPSC die through ROCK-dependent actomyosin hyperactivation, and Y-27632 raised cloning efficiency from roughly 1% to roughly 27% in the original report (Watanabe et al. 2007). Clump passaging with EDTA does not need it.

When should I remove the ROCK inhibitor?

At the first full medium change, conventionally 24 hours after plating. Leaving it on longer alters cytoskeletal state and morphology and becomes a confound in downstream readouts.

Can I use EDTA alone for single-cell passaging?

No. EDTA passaging produces small clumps, which is precisely what makes it gentle and why it is the standard for routine maintenance in defined medium (Beers et al. 2012). If you need countable single cells, you need an enzymatic step.

How often should I karyotype?

At least every 10 passages, and always before banking or before a definitive experiment. Culture-acquired changes accumulate progressively, most commonly on chromosomes 1, 12, 17 and 20, with a 20q11.21 amplicon in more than 20% of lines surveyed (ISCI 2011). Single-cell passaging increases the selection pressure that drives this.

What seeding density should I use after single-cell passaging?

A common starting range for expansion is 1–2 × 10⁴ cells/cm², but density is line- and medium-specific and must be titrated. Seeding too sparse after single-cell dissociation is a frequent cause of a culture that attaches and then stalls.

Does an animal-origin-free enzyme work on iPSC?

Animal-origin-free recombinant enzymes are used routinely in xeno-free pluripotent stem cell workflows as a class. For any specific product, ask the supplier what performance data exists for pluripotent cells. For CellTrypase, the manufacturer's measured data covers CHO-K1, HEK 293, MDCK and Vero only; iPSC is listed as an intended application with no performance figures attached. Qualify it on your own line before switching.

Why did my cells attach but fail to form colonies?

Usually seeding density, ROCK-inhibitor timing, or over-digestion that cleaved the adhesion and signalling proteins the cells need for the first 24 hours. Check those three before suspecting the medium or the matrix.

Reagents and Support

Browse dissociation enzymes in the BioHippo enzymes collection. For help designing a side-by-side qualification on your own iPSC line, ask a scientist.

Figures 1–6 are illustrative summaries of this protocol's decision points and of the published and manufacturer-reported values cited alongside them; they are not experimental data generated by BioHippo, and no figure should be read as a measurement made on your own cell line.

For research use only; not for use in diagnostic or therapeutic procedures. The R&D grade of CellTrypase is supplied for research use only. TrypLE™ is a trademark of Thermo Fisher Scientific and Accutase® is a registered trademark of its respective owner; these are referred to here for identification and comparison only, and BioHippo is not affiliated with, endorsed by, or sponsored by those companies. Incubation times, seeding densities and split ratios given here are starting values to be confirmed in your own hands, not specifications. Performance figures attributed to c-LEcta PIS CellTrypase v2.0 apply only to the four cell lines named; no performance data is claimed for iPSC or any other cell type. Peer-reviewed sources are cited inline and indexed in PubMed.